Figure 1: FACS analysis of HUCB cells used for treatment. Left panel shows a CD34 + cell depleted sample stained with an anti-CD34 antibody (0.4% CD34 + cells) directed to a non-competing CD34 epitope as compared to the antibody used for cell separation. Right panel shows a CD34 + cell enriched fraction (98.9%).